Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, you can take Wegovy on an empty stomach — and for the injection, your stomach contents at the time of the jab make no meaningful difference to how the medicine works. Wegovy is a once-weekly subcutaneous injection of semaglutide, a GLP-1 receptor agonist that works via your bloodstream rather than your gut lining, so a meal beforehand is not required and not prohibited. Where the empty-stomach question becomes genuinely important is for the oral semaglutide tablet (Wegovy tablets, approved by the MHRA in June 2026) — and those two situations have very different rules. This page walks through both, drawing on NHS guidance on semaglutide, so you can understand what applies to you before speaking with a prescriber about your own treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The pre-filled Wegovy pen delivers semaglutide into the fatty tissue just under your skin, the abdomen, thigh, or upper arm. From there it enters the bloodstream steadily over hours, completely bypassing the digestive process that determines whether an oral medicine is absorbed well or poorly. What you ate for breakfast, or whether you skipped it, has no bearing on that absorption.
This is one reason many people find a weekly injection practical: there is no specific window to hit, no fasting routine to remember, no clash with coffee. You pick a day of the week that suits you and stick to it. Our clinical team at nume often hears this framed as a concern by people comparing the injection to other medicines with strict food rules, it is a reasonable thing to wonder about, and the answer is reassuring.
Where food timing does matter for the injection is indirectly: eating smaller, lower-fat meals while adjusting to treatment can help reduce nausea, particularly in the first few weeks or after a dose increase. That is a comfort strategy, not a pharmacological one. If nausea is a problem, it is worth raising with your prescriber rather than adjusting your eating schedule independently. You can also read more about what to expect on our Wegovy treatment page.
The MHRA approved Wegovy tablets in June 2026, making the UK the first country in Europe to license an oral GLP-1 medicine for weight management. The active ingredient is still semaglutide, but the formulation works very differently. The tablet uses an absorption enhancer called SNAC to carry semaglutide across the stomach lining directly into the blood, and that mechanism only functions reliably when the stomach is empty and the environment is right.
The instructions are precise: take one tablet first thing in the morning, swallow it whole with no more than about 120 ml of plain water, and then wait at least 30 minutes before eating, drinking anything else (including tea or coffee), or taking other oral medicines. Breaking any part of that routine reduces absorption significantly. This is why the tablet is described as demanding a consistent morning habit rather than just being taken with a glass of water at any point in the day.
Doses escalate from 1.5 mg through 4 mg and 9 mg to the 25 mg maintenance dose, with at least a month at each level, a schedule your prescriber oversees throughout. For practical detail on how those steps work, the Wegovy tablet SmPC on the electronic Medicines Compendium is the authoritative reference. One advantage of the tablet over the injection is storage: no refrigeration needed, which makes it more straightforward when travelling.
Gastrointestinal side effects are the most commonly reported experience with semaglutide in any form, nausea, loose stools, constipation, reflux, and burping tend to cluster at the start of treatment or after stepping up to a new dose. They are not caused by taking the medicine on an empty stomach or a full one; they reflect how GLP-1 medicines slow gastric emptying and act on receptors in the gut and brain.
For the injection, some people find that eating a light, low-fat meal on injection day reduces nausea compared with eating a large meal shortly after. Others notice no difference at all. If you are weighing up whether taking Wegovy on an empty stomach gives you any practical advantage, the evidence suggests it makes no meaningful difference to absorption for the injection, though it may affect comfort for some people. If nausea is a problem, speaking with your prescriber before adjusting your eating schedule is the right step.
For the tablet, eating within the mandatory 30-minute window after dosing could affect absorption as well as comfort, so the waiting period serves both purposes. If nausea with the tablet is difficult to manage in the early weeks, speak with your prescriber before making any changes to the schedule.
People considering whether the injection or tablet suits them better often find this comparison of Wegovy and food timing a useful starting point, and those wondering about specific dose stages can explore what the guidance says for their particular situation.
Wegovy (in either form) is a prescription-only medicine. The only legal route to it is a clinical assessment by a qualified prescriber who can confirm it is appropriate for you personally. BMI, medical history, other medicines you take, and your overall health picture all factor into that decision. Lower BMI thresholds can apply for some ethnic backgrounds under UK guidance, and certain conditions or medicines may mean Wegovy is not suitable.
At nume, every consultation is personally reviewed by a GPhC-registered Independent Prescriber the same day. If treatment is approved and your order is placed by noon on a working day, the pen is dispatched that afternoon and delivered by DPD the next working day in plain, unbranded packaging, tracked to your door. For anyone researching the cost side of things, our Wegovy treatment and pricing page sets out what is included in one transparent price: consultation, prescription, delivery, and 7-day aftercare, with no subscription and no auto-renewal.
If you have questions before starting, our team is straightforward to reach via our contact page, or you can start a free consultation and have a prescriber review your case directly.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.